AU Patent

AU2011202162B2 — Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Assigned to Allergan Finance LLC · Expires 2013-11-21 · 12y expired

What this patent protects

Abstract A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a 5 thiazolidinedione derivative is herein disclosed and described.

USPTO Abstract

Abstract A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a 5 thiazolidinedione derivative is herein disclosed and described.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011202162B2
Jurisdiction
AU
Classification
—
Expires
2013-11-21
Drug substance claim
No
Drug product claim
No
Assignee
Allergan Finance LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.